Skip to main content

Therapeutic Window Beyond Cerebral Ischemic Reperfusion Injury

  • Chapter
  • First Online:
Cerebral Ischemic Reperfusion Injuries (CIRI)

Part of the book series: Springer Series in Translational Stroke Research ((SSTSR))

Abstract

Reperfusion therapy has been one of the major breakthroughs in clinical medicine. Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (tPA) remains the only FDA approved therapy for acute ischemic stroke (AIS). It is effective within 4.5 h of symptom onset and better if given earlier. More recently, five randomized controlled trials (RCTs) demonstrated the efficacy of endovascular therapy (EVT) for AIS from large vessel occlusion (LVO) in the anterior circulation within 6–12 h of symptom onset. Reperfusion injury with symptomatic intracerebral hemorrhage (sICH) is the most feared complication of reperfusion therapy. However, the rate of sICH only increases slightly with longer delay to reperfusion. Numerous case reports and cohort studies have supported the expanding of therapeutic window up to 24 h in the anterior circulation and beyond in the posterior circulation. In patients with acute stroke from LVO in the posterior circulation, EVT up to 48 h after symptom onset was seldom futile in the absence of extensive baseline ischemia and longer treatment delay does not increase the risk of sICH. Such clinical studies have clearly pushed the boundary of our understanding about reperfusion injury and therapeutic time window. Laboratory and translational studies may better define collateral circulation, venous drainage, and the molecular mechanisms of contrast extravasation, hemorrhagic conversion, and sICH. A solid scientific foundation is needed for expanding therapeutic window way beyond reperfusion injury.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.

    Article  Google Scholar 

  2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13):1017–25.

    Article  CAS  PubMed  Google Scholar 

  3. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352(9136):1245–51.

    Article  CAS  PubMed  Google Scholar 

  4. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768–74.

    Article  PubMed  Google Scholar 

  5. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–29.

    Article  CAS  PubMed  Google Scholar 

  6. Wahlgren N, Ahmed N, Dávalos A, Hacke W, Millán M, Muir K, et al. Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372(9646):1303–9.

    Article  CAS  PubMed  Google Scholar 

  7. Lansberg MG, Bluhmki E, Thijs VN. Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis. Stroke. 2009;40(7):2438–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Saver JL, Gornbein J, Grotta J, et al. Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window. Stroke. 2009;40(7):2433–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695–703.

    Article  CAS  PubMed  Google Scholar 

  10. Yeo LL, Paliwal P, Teoh HL, Seet RC, Chan BP, Liang S, et al. Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke. JAMA Neurol. 2013;70:353–8.

    Article  PubMed  Google Scholar 

  11. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003–11. https://doi.org/10.1001/jama.282.21.2003.

    Article  PubMed  CAS  Google Scholar 

  12. Chopko BK, Kerber C, Wong W, Georgy B. Transcatheter snare removal of acute middle cerebral artery thromboembolism: technical case report. Neurosurgery. 2000;46:1529–31.

    Article  CAS  PubMed  Google Scholar 

  13. Mayer TE, Hamann GF, Brueckmann H. Treatment of basilar artery embolism with mechanical extraction device: necessity of flow reversal. Stroke. 2002;33:2232–5.

    Article  PubMed  Google Scholar 

  14. Yu W, Binder D, Foster-Barber A, Malek R, Smith WS, Higashida RT. Endovascular embolectomy of acute basilar artery occlusion. Neurology. 2003;61:1421–3.

    Article  CAS  PubMed  Google Scholar 

  15. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.

    Article  CAS  PubMed  Google Scholar 

  16. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.

    Article  CAS  PubMed  Google Scholar 

  17. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–30.

    Article  CAS  PubMed  Google Scholar 

  18. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–95.

    Article  CAS  PubMed  Google Scholar 

  19. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.

    Article  CAS  PubMed  Google Scholar 

  20. Khatri P, McKinney AM, Swenson B, et al. Blood- brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012;79(suppl 1):S52–7.

    Article  PubMed  Google Scholar 

  21. Cheng T, Petraglia AL, Li Z, Thiyagarajan M, Zhong Z, Wu Z, Liu D, Maggirwar SB, Deane R, Fernandez JA, LaRue B, Griffin JH, Chopp M, Zlokovic BV. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med. 2006;12:1278–85.

    Article  CAS  PubMed  Google Scholar 

  22. Abou-Chebl A, Yadav JS, Reginelli JP, et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol. 2004;43:1596–601.

    Article  PubMed  Google Scholar 

  23. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol. 2008;63:52–60.

    Article  PubMed  Google Scholar 

  24. Albers GW, Thiji VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508–17.

    Article  PubMed  Google Scholar 

  25. Campbell BC, Christensen S, Parsons MW, et al. Advanced imaging improves prediction of hemorrhage after stroke thrombolysis. Ann Neurol. 2013;73:510–9.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Gupta R, Vora NA, Horowitz MB, et al. Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke. 2006;37:986–90.

    Article  PubMed  Google Scholar 

  27. Abou-Chebl A, Reginelli J, Bajzer CT, Yadav JS. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv. 2007;69:690–6.

    Article  PubMed  Google Scholar 

  28. Schonewille WJ, Wijman CA, Michel P, et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 2009;8:724–30.

    Article  PubMed  Google Scholar 

  29. Strbian D, Sairanen T, Silvennoinen H, et al. Thrombolysis of basilar artery occlusion: impact of baseline ischemia and time. Ann Neurol. 2013;73:688–94.

    Article  PubMed  Google Scholar 

  30. Sarikaya H, Arnold M, Engelter ST, Lyrer PA, Mattle HP, Georgiadis D, et al. Outcomes of intravenous thrombolysis in posterior versus anterior circulation stroke. Stroke. 2011;42:2498–502.

    Article  PubMed  Google Scholar 

  31. Saver JL, Goyal M, Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316:1279–88.

    Article  PubMed  Google Scholar 

  32. Mourand I, Machi P, Milhaud D, et al. Mechanical thrombectomy with the solitaire device in acute basilar artery occlusion. J Neurointerv Surg. 2014;6:200–4.

    Article  PubMed  Google Scholar 

  33. Carneiro AA, Rodrigues JT, Pereira JP, Alves JV, Xavier JA. Mechanical thrombectomy in patients with acute basilar occlusion using stent retrievers. Interv Neuroradiol. 2015;21(6):710–4. https://doi.org/10.1177/1591019915609781.

    Article  PubMed  PubMed Central  Google Scholar 

  34. van Houwelingen RC, Luijckx GJ, Mazuri A, et al. Safety and outcome of intra-arterial treatment for basilar artery occlusion. JAMA Neurol. 2016;73:1225–30.

    Article  PubMed  Google Scholar 

  35. Singer OC, Berkefeld J, Nolte CH, et al. Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol. 2015;77(3):415–24.

    Article  PubMed  Google Scholar 

  36. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol. 2006;27:1177–82.

    PubMed  CAS  Google Scholar 

  37. Nikoubashman O, Reich A, Gindullis M, et al. Clinical significance of post-interventional cerebral hyperdensities after endovascular mechanical thrombectomy in acute ischaemic stroke. Neuroradiology. 2014;56:41–50.

    Article  PubMed  Google Scholar 

  38. Parrilla G, García-Villalba B, Espinosa de Rueda M, et al. Hemorrhage/contrast staining areas after mechanical intra-arterial thrombectomy in acute ischemic stroke: imaging findings and clinical significance. AJNR Am J Neuroradiol. 2012;33:1791–6.

    Article  CAS  PubMed  Google Scholar 

  39. Lindsberg PJ, Pekkola J, Strbian D, Sairanen T, Mattle HP, Schroth G. Time window for recanalization in basilar artery occlusion: speculative synthesis. Neurology. 2015;85:1806–15. https://doi.org/10.1212/WNL.0000000000002129.

    Article  PubMed  Google Scholar 

  40. Cross DT, Moran CJ, Akins PT, Angtuaco EE, Derdeyn CP, Diringer MN. Collateral circulation and outcome after basilar artery thrombolysis. Am J Neuroradiol. 1998;19:1557–63.

    PubMed  Google Scholar 

  41. Jung S, Mono ML, Fischer U, et al. Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysis. Stroke. 2011;42:1946–51.

    Article  PubMed  Google Scholar 

  42. Jung S, Gilgen M, Slotboom J, et al. Factors that determine penumbral tissue loss in acute ischaemic stroke. Brain. 2013;136:3554–60.

    Article  PubMed  Google Scholar 

  43. Kang HS, Han MH, Kim SH, Kwon OK, Roh HG, Koh YC. Anterior spinal artery as a collateral channel in cases of bilateral vertebral arterial steno-occlusive diseases. Am J Neuroradiol. 2007;28:222–5.

    PubMed  Google Scholar 

  44. Lescher S, Samaan T, Berkefeld J. Evaluation of the pontine perforators of the basilar artery using digital subtraction angiography in high resolution and 3D rotation technique. Am J Neuroradiol. 2014;35:1942–7.

    Article  CAS  PubMed  Google Scholar 

  45. Vergouwen MD, Algra A, Pfefferkorn T, Weimar C, Rueckert CM, Thijs V, Kappelle LJ, Schonewille WJ. Time is brain(stem) in basilar artery occlusion. Stroke. 2012;43:3003–6.

    Article  PubMed  Google Scholar 

  46. Yoon W, Kim SK, Heo TW, Baek BH, Lee YY, Kang HK. Predictors of good outcome after stent-retriever thrombectomy in acute basilar artery occlusion. Stroke. 2015;46:2972–5.

    Article  PubMed  Google Scholar 

  47. Lai TT, Lavian M, Al-Khoury L, Suzuki S, Yu W. Case report of endovascular therapy of acute basilar artery occlusion: beyond the restricted time window. Neurol Cases. 2016;3(2):1–4.

    Google Scholar 

  48. Yu W, Kostanian V, Fisher M. Endovascular recanalization of basilar artery occlusion 80 days after symptom onset. Stroke. 2007;38(4):1387–9.

    Article  PubMed  Google Scholar 

  49. Grigoriadis S, Gomori JM, Grigoriadis N, Cohen JE. Clinically successful late recanalization of basilar artery occlusion in childhood: what are the odds? Case report and review of the literature. J Neurol Sci. 2007;260(1–2):256–60.

    Article  PubMed  Google Scholar 

  50. Kostanian, Yu W. Successful recanalization of chronic basilar artery occlusion. Neurol Cases. 2014;1(1):1–3.

    Google Scholar 

  51. Lin R, Aleu A, Jankowitz B, et al. Endovascular revascularization of chronic symptomatic vertebrobasilar occlusion. J Neuroimaging. 2012;22(1):74–9.

    Article  PubMed  Google Scholar 

  52. Aghaebrahim A, Jovin T, Jadhav AP, Noorian A, Gupta R, Nogueira RG. Endovascular recanalization of complete subacute to chronic atherosclerotic occlusions of intracranial arteries. J Neurointerv Surg. 2014;6:645–8.

    Article  PubMed  Google Scholar 

  53. Espinosa de Rueda M, Parrilla G, Zamarro J, et al. Treatment of acute vertebrobasilar occlusion using thrombectomy with stent retrievers: initial experience with 18 patients. AJNR Am J Neuroradiol. 2013;34:1044–8.

    Article  CAS  PubMed  Google Scholar 

  54. Möhlenbruch M, Stampfl S, Behrens L, et al. Mechanical thrombectomy with stent retrievers in acute basilar artery occlusion. AJNR Am J Neuroradiol. 2014;35:959–64.

    Article  PubMed  Google Scholar 

  55. Nagel S, Kellert L, Möhlenbruch M, et al. Improved clinical outcome after acute basilar artery occlusion since the introduction of endovascular thrombectomy devices. Cerebrovasc Dis. 2013;36:394–400.

    Article  CAS  PubMed  Google Scholar 

  56. Park BS, Kang CW, Kwon HJ, et al. Endovascular mechanical thrombectomy in basilar artery occlusion: initial experience. J Cerebrovasc Endovasc Neurosurg. 2013;15:137–44.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Raoult H, Eugène F, Ferré JC, et al. Prognostic factors for outcomes after mechanical thrombectomy with solitaire stent. J Neuroradiol. 2013;40:252–9.

    Article  PubMed  Google Scholar 

  58. Mordasini P, Brekenfeld C, Byrne JV, et al. Technical feasibility and application of mechanical thrombectomy with the solitaire FR revascularization device in acute basilar artery occlusion. AJNR Am J Neuroradiol. 2013;34:159–63.

    Article  CAS  PubMed  Google Scholar 

  59. Andersson T, Kuntze Söderqvist Å, Söderman M. Mechanical thrombectomy as the primary treatment for acute basilar artery occlusion: experience from 5 years of practice. J Neurointerv Surg. 2013;5:221–5.

    Article  PubMed  Google Scholar 

  60. Lefevre PH, Lainay C, Thouant P, et al. Solitaire FR as a first-line device in acute intracerebral occlusion: a single-centre retrospective analysis. J Neuroradiol. 2014;41:80–6.

    Article  PubMed  Google Scholar 

  61. Fesl G, Holtmannspoetter M, Patzig M, et al. Mechanical thrombectomy in basilar artery thrombosis: technical advances and safety in a 10-year experience. Cardiovasc Intervent Radiol. 2014;37:355–61.

    Article  PubMed  Google Scholar 

  62. Baek J, Yoon W, Kim S. Acute basilar artery occlusion: outcome of mechanical thrombectomy with solitaire stent within 8 hours of stroke onset. Am J Neuroradiol. 2014;35:989–93.

    Article  CAS  PubMed  Google Scholar 

  63. Gory B, Eldesouky I, Sivan-Hoffmann R, et al. Outcomes of stent retriever thrombectomy in basilar artery occlusion: an observational study and systematic review. J Neurol Neurosurg Psychiatry. 2016;87(5):520–5. https://doi.org/10.1136/jnnp-2014-310250.

    Article  PubMed  Google Scholar 

  64. Mokin M, Sonig A, Sivakanthan S, et al. Clinical and procedural predictors of outcomes from the endovascular treatment of posterior circulation strokes. Stroke. 2016;47:782–8.

    PubMed  CAS  Google Scholar 

  65. Du S, Mao G, Li D, Qiu M, Nie Q, Zhu H, Yang Y, Zhang Y, Li Y, Wu Z. Mechanical thrombectomy with the Solitaire AB stent for treatment of acute basilar arteryocclusion: a single-center experience. J Clin Neurosci. 2016;32:67–71.

    Article  PubMed  Google Scholar 

  66. Alonso de Leciñana M, Kawiorski MM, Ximénez-Carrillo Á, Cruz-Culebras A, García Pastor A, Martínez-Sánchez P, et al. Madrid Stroke Network. Mechanical thrombectomy for basilar artery thrombosis: a comparison of outcomes with anterior circulation occlusions. J Neurointerv Surg. 2016. https://doi.org/10.1136/neurintsurg-2016-012797.

  67. Dashti SR, Park MS, Stiefel MF, McDougall CG, Albuquerque FC. Endovascular recanalization of the subacute to chronically occluded basilar artery: initial experience and technical considerations. Neurosurgery. 2010;66(4):825–32.

    Article  PubMed  Google Scholar 

  68. Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke. 2010;41:1996–2000.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wengui Yu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yu, W., Liu, L. (2018). Therapeutic Window Beyond Cerebral Ischemic Reperfusion Injury. In: Jiang, W., Yu, W., Qu, Y., Shi, Z., Luo, B., Zhang, J. (eds) Cerebral Ischemic Reperfusion Injuries (CIRI). Springer Series in Translational Stroke Research. Springer, Cham. https://doi.org/10.1007/978-3-319-90194-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90194-7_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90193-0

  • Online ISBN: 978-3-319-90194-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics